Recursion Pharmaceuticals Ownership | Who Owns Recursion Pharmaceuticals?
Recursion Pharmaceuticals Ownership Summary
Recursion Pharmaceuticals is owned by 75.53% institutional investors, 3.14% insiders, and 21.34% retail investors. Vanguard group is the largest institutional shareholder, holding 12.04% of RXRX shares. ARK Disruptive Innovation Full Composite is the top mutual fund, with 4.80% of its assets in Recursion Pharmaceuticals shares.
RXRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Recursion Pharmaceuticals | 75.53% | 3.14% | 21.34% |
| Sector | Healthcare Stocks | 279.18% | 10.62% | -189.80% |
| Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 34.01M | 12.04% | $229.91M |
| Ark investment management | 32.35M | 11.45% | $218.66M |
| Baillie gifford | 24.86M | 8.80% | $168.08M |
| Blackrock funding, inc. /de | 23.44M | 8.29% | $158.43M |
| Blackrock | 17.31M | 7.33% | $129.83M |
| Softbank group | 14.67M | 5.19% | $99.15M |
| Mubadala investment co pjsc | 12.99M | 4.60% | $87.78M |
| Kinnevik ab (publ) | 11.91M | 4.21% | $80.48M |
| State street | 8.75M | 3.71% | $65.62M |
| Novo | 10.11M | 3.58% | $68.37M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Kinnevik ab (publ) | 11.91M | 100.00% | $80.48M |
| Dcvc opportunity fund ii gp | 3.95M | 23.64% | $26.71B |
| Data collective iv gp | 5.94M | 17.75% | $40.16B |
| Nvidia | 7.71M | 17.11% | $52.10M |
| Mic capital management uk llp | 9.64M | 9.23% | $65.19M |
| Novo | 10.11M | 4.14% | $68.37M |
| Nan fung group | 664.61K | 3.84% | $4.49M |
| Pivotal bioventure partners investment advisor | 595.52K | 2.72% | $4.03M |
| Ark investment management | 32.35M | 1.82% | $218.66M |
| Carroll investors | 246.99K | 0.94% | $1.67M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Softbank group | 14.67M | 0.42% | 14.67M |
| Novo | 10.11M | 4.14% | 10.11M |
| Vanguard group | 34.01M | 0.00% | 9.74M |
| Blackrock | 17.31M | 0.00% | 4.99M |
| Norges bank | 3.47M | 0.00% | 3.47M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -7.73M |
| Deerfield management company, l.p. (series c) | - | - | -2.31M |
| State street | 8.75M | 0.00% | -1.60M |
| Platinum investment management | 395.67K | 0.12% | -1.40M |
| Fmr | 7.07M | 0.00% | -1.29M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Softbank group | 14.67M | 0.42% | 14.67M | $99.15M |
| Novo | 10.11M | 4.14% | 10.11M | $68.37M |
| Norges bank | 3.47M | 0.00% | 3.47M | $23.43M |
| Nan fung group | 664.61K | 3.84% | 664.61K | $4.49M |
| Pivotal bioventure partners investment advisor | 595.52K | 2.72% | 595.52K | $4.03M |
Sold Out
| Holder | Change |
|---|---|
| Nbc securities | -1.00 |
| Financial gravity asset management | -4.00 |
| Householder group estate & retirement specialist | -11.00 |
| Gradient investments | -15.00 |
| Western pacific wealth management, lp | -20.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 350 | 4.79% | 304,203,724 | -0.17% | 75 | 0.65% | 204 | 2.51% | 72 | 14.29% |
| Dec 31, 2024 | 308 | 10.79% | 289,638,352 | 11.01% | 102 | 1.20% | 181 | 16.77% | 56 | 12.00% |
| Sep 30, 2024 | 275 | -1.43% | 260,863,978 | 3.59% | 92 | 0.81% | 154 | -13.97% | 49 | - |
| Jun 30, 2024 | 277 | 8.20% | 251,804,695 | 20.07% | 106 | 1.35% | 177 | 12.74% | 49 | -5.77% |
| Mar 31, 2024 | 256 | 25.49% | 209,712,724 | 1.55% | 88 | 1.13% | 157 | 38.94% | 52 | 15.56% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| ARK Disruptive Innovation Full Composite | 19.28M | 4.80% | 1.00M |
| ARK Innovation ETF | 18.67M | 4.59% | -27.99K |
| Scottish Mortgage Ord | 18.17M | 4.47% | - |
| ARK Genomic Revolution | 12.61M | 3.14% | 1.10M |
| ARK Genomic Revolution ETF | 11.70M | 2.88% | - |
| Vanguard Total Stock Mkt Idx Inv | 10.97M | 2.70% | 38.00K |
| Vanguard Small Cap Index | 8.67M | 2.13% | 60.90K |
| Vanguard US Total Market Shares ETF | 8.01M | 1.99% | 1.01M |
| SPDR® S&P Biotech ETF | 6.75M | 1.66% | 8.73K |
| iShares Russell 2000 ETF | 6.43M | 1.58% | 3.15K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 27, 2025 | Gibson Christopher | Chief Executive Officer | Sell | $836.99K |
| Mar 05, 2025 | Gibson Christopher | Chief Executive Officer | Sell | $131.60K |
| Mar 06, 2025 | Gibson Christopher | Chief Executive Officer | Sell | $127.40K |
| Feb 05, 2025 | Gibson Christopher | Chief Executive Officer | Sell | $153.60K |
| Feb 06, 2025 | Gibson Christopher | Chief Executive Officer | Sell | $162.40K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | 7 |
| 2024 Q4 | - | 15 |
| 2024 Q3 | - | 21 |
| 2024 Q2 | - | 22 |
RXRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools